共 217 条
[1]
Te HS(2010)Epidemiology of hepatitis B and C viruses: a global overview Clin Liver Dis 14 1-21
[2]
Jensen DM(2011)Hot-topic debate on hepatitis C virus: the type of immunosuppression matters Liver Transpl 17 S20-S23
[3]
Trotter JF(2011)Clinical practice. Chronic hepatitis C infection N Engl J Med 364 2429-2438
[4]
Rosen HR(2007)Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation Liver Transpl 13 122-129
[5]
Terrault NA(2009)A practical guide to the management of HCV infection following liver transplantation Am J Transplant 9 1707-1713
[6]
Shiffman ML(2000)Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation Hepatology 32 852-858
[7]
Lok AS(2012)Immunosuppression, liver injury and post-transplant HCV recurrence J Viral Hepat 19 1-8
[8]
Saab S(2004)Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C Transplant Proc 36 2757-2761
[9]
Tong L(2011)Outcome of induction immunosuppression for liver transplantation comparing anti-thymocyte globulin, daclizumab, and corticosteroid Transpl Int 24 640-650
[10]
Brown RS(2007)Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation Liver Transpl 13 1039-1044